Alleaves Incorporated acquired Bio-Tech Medical Software, Inc. from Helix Technologies, Inc. for $30 million on February 10, 2023. The Buyer paid $20 million in cash at closing and is required to make twelve equal monthly payments totaling $10 million commencing March 2023, which subsequent payments are guaranteed by certain affiliates of the Buyer. On or before the tenth (10 th ) day of each month (or the next immediately succeeding Business Day if not a Business Day) commencing on March 10, 2023 and ending on February 8, 2024, Buyer shall remit to Seller by wire transfer of immediately available funds the sum of Eight Hundred Thirty-Three Thousand Three Hundred Thirty-Three Dollars and Thirty-Three Cents ($833,333.33); provided that the payment made on or before February 8, 2024, shall be made in the amount of Eight Hundred Thirty-Three Thousand Three Hundred Thirty-Three Dollars and Thirty-Seven Cents ($833,333.37). William Kushner of PremierCounsel, LLP acted as legal advisor to Alleaves. Darrick M. Mix acted as legal advisor to Duane Morris LLP.

Alleaves Incorporated completed the acquisition of Bio-Tech Medical Software, Inc. from Helix Technologies, Inc. on February 10, 2023.